Daniel Gehle (Epidemiology) will defend his project titled “Universal Risk Stratification in Stage I-III Cutaneous Melanoma Using 31-Gene Expression Profiling: a Prospective Single-center Study” on Wednesday, April 30, at 10 a.m. CDT in Rm 308, 910 Madison Building. Dr. Feng Liu-Smith is his advisor.